Related Experiment Video
Updated: Dec 20, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Current regulatory approaches for accessing potential COVID-19 therapies
Vesa Halimi1, Armond Daci2, Simona Stojanovska3
11Faculty of Pharmacy, University Ss. Cyril and Methodius, Skopje, North Macedonia.
Abstract:
This commentary aims to elaborate challenges in the regulatory approaches for accessing and investigating COVID-19 potential therapies either with off-label use, compassionate use, emergency use or for clinical trials. Since no therapies have been formally approved and completely effective and safe to date, the best clinical choice is acquired only after consistent and fair communication and collaboration between licensed clinicians, researchers, regulatory authorities, manufacturers and patients.
Related Concept Videos
Drug Regulation
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Drug Control Governance: Regulatory Bodies and Their Impact
Microorganisms in Medicine and Therapeutics
Clinical Trials: Overview
Drug Discovery: Overview

